Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2024 Sep 3;7(9):e2434650.
doi: 10.1001/jamanetworkopen.2024.34650.

The Promise and Perils of Oncology Care in Medicare Advantage

Michael Anne Kyle  1 , Nancy L Keating  1   2
Affiliations
Comment

The Promise and Perils of Oncology Care in Medicare Advantage

Michael Anne Kyle et al. JAMA Netw Open. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest Disclosures: Dr Kyle reported receiving grants from National Cancer Institute during the conduct of the study. No other disclosures were reported.

Comment on

References

    1. Kalidindi Y, Jung J, Feldman R, Carlin C, Song G, Mitchell A. Resource use and care quality differences among Medicare beneficiaries undergoing chemotherapy. JAMA Netw Open. 2024;7(9):e2434707. doi: 10.1001/jamanetworkopen.2024.34707 - DOI - PMC - PubMed
    1. Kyle MA, Dusetzina SB, Keating NL. Evaluation of trends in oncology drug spending in Medicare, 2016 to 2020. JAMA Netw Open. 2022;5(7):e2221468. doi: 10.1001/jamanetworkopen.2022.21468 - DOI - PMC - PubMed
    1. Giordano SH, Niu J, Chavez-MacGregor M, et al. Estimating regimen-specific costs of chemotherapy for breast cancer: observational cohort study. Cancer. 2016;122(22):3447–3455. doi: 10.1002/cncr.30274 - DOI - PMC - PubMed
    1. The Oncology Care Model Evaluation Team. Evaluation of the Oncology Care Model: final report. Abt Global. 2024. Accessed August 14, 2024. https://www.cms.gov/priorities/innovation/data-and-reports/2024/ocm-fina...
    1. Anderson KE, Polsky D, Dy S, Sen AP. Prescribing of low- versus high-cost Part B drugs in Medicare Advantage and traditional Medicare. Health Serv Res. 2022;57(3):537–547. doi: 10.1111/1475-6773.13912 - DOI - PMC - PubMed

Publication types